Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Almac Group is a private, global pharmaceutical services company serving biopharma clients across the drug development lifecycle. Its businesses span API and chemical development, formulation and drug product development, analytical and solid-state services, clinical trial supply, interactive response technology, biomarker and companion diagnostics, and commercial manufacturing and packaging. The company operates as an integrated CDMO/CRO rather than a therapeutics developer with an internal clinical pipeline. Almac has a particularly strong position in small molecules, peptides, clinical supply services, and trial technology, and it also supports advanced therapies including gene therapy programs. The group is headquartered in Craigavon, Northern Ireland, with major operations in the United States and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alamc Group.